CBD was linked to stronger beta-band brain connectivity in a small EEG subset

Cannabidiol and fronto-parietal EEG connectivity in autistic children.

Cerebral cortex (New York, N.Y. : 1991) • • Clinical Trial • Highly Relevant
🤖

AI Summary

This study asked whether oral cannabidiol (CBD) changes resting-state brain connectivity in autistic children. It analyzed EEG recordings from a subset of 18 children who took part in a randomized, double-blind, placebo-controlled crossover trial. The children completed 12-week CBD and placebo periods, separated by an eight-week washout.

After CBD, connectivity between right frontal and right inferior-parietal electrodes increased in the beta frequency band; this finding remained statistically significant after correction for multiple comparisons. An increase in alpha-band connectivity did not remain significant after correction, and no significant connectivity changes were found after placebo. These EEG findings are preliminary: the abstract does not establish that the change improves behavior or has clinical benefit. The small EEG subset and need for replication in larger samples limit what can be concluded. This is an abstract-based summary.

💡 Key Findings

1
Following the CBD period, right fronto-parietal beta-band connectivity increased, and the finding remained significant after false-discovery-rate correction.
Good
70%
2
An increase in alpha-band connectivity was not significant after correction for multiple comparisons.
High
90%
3
The placebo period showed no significant connectivity changes in any frequency band.
High
80%
4
The EEG analysis involved 18 autistic children; larger studies are needed, and the findings do not establish clinical or behavioral benefit.
High
95%

📄 Original Abstract

Autistic children often show altered brain network connectivity, including circuitry implicated in social cognition. Cannabidiol (CBD) has emerged as a potential therapy for autism, but its neural mechanisms remain under-researched. Here, we analyze resting-state data collected as part of a double-blind, placebo-controlled crossover trial, to explore whether 12 weeks of oral CBD oil could modulate functional connectivity in autistic children. Twenty-nine autistic children (5 to 12 years) completed two 12-week intervention periods (CBD and placebo, randomized) separated by an 8-week washout. Before and after each period, 5 min of eyes-open resting-state electroencephalography (EEG) were obtained from a subset of 18 participants (8 female). Functional connectivity was calculated across 16 electrode-pairs in the delta, theta, alpha, beta, and gamma bands. Beta-band connectivity between the right frontal and right inferior-parietal electrodes increased following CBD (P = 0.001, false discovery rate [FDR]-corrected P [pFDR] = 0.022), and alpha connectivity showed an increase that did not remain following FDR correction (P = 0.036, pFDR = 0.428). No significant differences were observed following placebo for any frequency band (pFDR > 0.69). This study provides preliminary evidence that 12 weeks of cannabidiol is associated with an increase in right fronto-parietal (F4-P8) functional connectivity in autistic children, most pronounced in the beta-band. Replication in larger samples is needed to confirm generalizability and clinical relevance. This study explored whether cannabidiol (CBD) oil changes brain communication in autistic children. After 12 weeks, children showed stronger activity links between brain regions involved in attention and social understanding, while placebo did not show this pattern. These early findings suggest CBD may influence brain function in ways that could support behavior, but larger studies are needed to confirm real-world benefits.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.